SMTL ID : 5uiq.3 (3 other biounits)

Crystal structure of IRAK4 in complex with compound 9

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.64 Å

Oligo State

monomer

Ligands

1 x 8BV: 2-[(propan-2-yl)oxy]benzamide(Non-covalent)

8BV.1: 10 residues within 4Å: Chain A: V.63, A.74, K.76, V.109, Y.125, V.126, Y.127, M.128, L.181, S.191 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.63, A:V.63, A:V.109, A:Y.125, A:Y.125 Hydrogen bonds: A:V.126, A:M.128

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lee, K.L. et al., Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design. J. Med. Chem. (2017)

Release Date

2017-05-24

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence